Ran Luo

4.5k total citations · 1 hit paper
55 papers, 2.6k citations indexed

About

Ran Luo is a scholar working on Nephrology, Oncology and Molecular Biology. According to data from OpenAlex, Ran Luo has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Ran Luo's work include MRI in cancer diagnosis (7 papers), Renal Diseases and Glomerulopathies (6 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Ran Luo is often cited by papers focused on MRI in cancer diagnosis (7 papers), Renal Diseases and Glomerulopathies (6 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Ran Luo collaborates with scholars based in China, New Zealand and India. Ran Luo's co-authors include Shuwang Ge, Gang Xu, Yichun Cheng, Ying Yao, Junhua Li, Lei Dong, Zhixiang Wang, Meng Zhang, Kun Wang and Dengbin Wang and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Ran Luo

48 papers receiving 2.5k citations

Hit Papers

Kidney disease is associated with in-hospital death of pa... 2020 2026 2022 2024 2020 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Luo China 18 1.6k 659 646 530 398 55 2.6k
Yichun Cheng China 14 1.6k 1.0× 651 1.0× 608 0.9× 524 1.0× 391 1.0× 37 2.5k
Shuwang Ge China 24 1.6k 1.0× 672 1.0× 763 1.2× 721 1.4× 477 1.2× 66 3.0k
Jan M. Griffin United States 18 810 0.5× 478 0.7× 399 0.6× 187 0.4× 237 0.6× 65 2.1k
Mahesh V. Madhavan United States 23 1.1k 0.7× 603 0.9× 411 0.6× 173 0.3× 1.6k 3.9× 85 4.0k
Meghan E. Sise United States 32 626 0.4× 227 0.3× 727 1.1× 1.2k 2.2× 480 1.2× 133 3.7k
Grigoris Gerotziafas France 30 1.3k 0.8× 654 1.0× 657 1.0× 58 0.1× 799 2.0× 163 4.3k
Ismaı̈l Elalamy France 32 1.3k 0.9× 739 1.1× 693 1.1× 62 0.1× 884 2.2× 241 4.9k
Daniela Tomasoni Italy 25 1.2k 0.8× 785 1.2× 443 0.7× 55 0.1× 316 0.8× 83 3.4k
Hanny Al‐Samkari United States 31 979 0.6× 451 0.7× 461 0.7× 72 0.1× 467 1.2× 193 3.8k
K.M. Kant Netherlands 5 3.6k 2.3× 2.0k 3.1× 1.3k 2.0× 67 0.1× 418 1.1× 7 4.6k

Countries citing papers authored by Ran Luo

Since Specialization
Citations

This map shows the geographic impact of Ran Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Luo more than expected).

Fields of papers citing papers by Ran Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Luo. The network helps show where Ran Luo may publish in the future.

Co-authorship network of co-authors of Ran Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Luo. A scholar is included among the top collaborators of Ran Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Luo. Ran Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Luo, Ran, et al.. (2025). Prediction of First-Onset Cerebral Infarction Risk in Patients with Acute Myocardial Infarction: A Retrospective Cohort Study. International Journal of General Medicine. Volume 18. 3501–3513. 1 indexed citations
5.
Luo, Ran, Tianci Xu, Lu Wang, et al.. (2024). Design, synthesis and antitumor effects of lupeol quaternary phosphonium salt derivatives. Bioorganic & Medicinal Chemistry. 113. 117934–117934. 2 indexed citations
6.
Zhao, Wenjing, Fang Wan, Ran Luo, et al.. (2024). Association between asthma and cardiovascular disease: evidence from the national health and nutrition examination survey 1999–2018. Frontiers in Cardiovascular Medicine. 11. 1367576–1367576. 1 indexed citations
7.
Liang, Yubin, Ran Luo, Ying Mao, et al.. (2024). VX-765 attenuates secondary damage and β-amyloid accumulation in ipsilateral thalamus after experimental stroke in rats. Experimental Neurology. 385. 115097–115097. 3 indexed citations
8.
Xu, Tianhong, Ran Luo, Zhixin Chen, et al.. (2024). Design, Synthesis, and Antitumor Activity Evaluation of Novel Lupeol-3-urea/thiourea Derivatives. Russian Journal of General Chemistry. 94(10). 2759–2769. 1 indexed citations
9.
Wang, Zufeng, et al.. (2024). Deletion of lymphotoxin-β receptor (LTβR) protects against acute kidney injury by PPARα pathway. Molecular Medicine. 30(1). 254–254.
10.
Zhang, Jinxie, Liuchang Wang, Fanqiang Meng, et al.. (2024). Neoantigen sequestrated autophagosomes as therapeutic cancer vaccines. Journal of Controlled Release. 376. 369–381. 6 indexed citations
11.
Wang, Lijun, Ran Luo, Yanhong Chen, et al.. (2023). Breast Cancer Growth on Serial MRI : Volume Doubling Time Based on 3‐Dimensional Tumor Volume Assessment. Journal of Magnetic Resonance Imaging. 58(4). 1303–1313.
12.
Chen, Yanhong, Lijun Wang, Ran Luo, et al.. (2023). Focal breast edema and breast edema score on T2-weighted images provides valuable biological information for invasive breast cancer. Insights into Imaging. 14(1). 73–73. 8 indexed citations
13.
Luo, Ran, et al.. (2021). Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital. BMC Infectious Diseases. 21(1). 397–397. 11 indexed citations
14.
Liu, Huanhuan, Yanhong Chen, Lijun Wang, et al.. (2021). A deep learning model integrating mammography and clinical factors facilitates the malignancy prediction of BI-RADS 4 microcalcifications in breast cancer screening. European Radiology. 31(8). 5902–5912. 56 indexed citations
15.
Cheng, Yichun, Ran Luo, Dan Chang, et al.. (2021). Low-Carbohydrate-Diet Score and Mortality in Adults With and Without Chronic Kidney Disease: Results From the Third National Health and Nutrition Examination Survey. Journal of Renal Nutrition. 32(3). 301–311. 5 indexed citations
16.
17.
Yang, Yi, Ran Luo, Yichun Cheng, et al.. (2020). Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis. BMC Nephrology. 21(1). 122–122. 29 indexed citations
18.
Luo, Ran, Yi Yang, Yichun Cheng, et al.. (2020). Plasma chemokine CXC motif-ligand 16 as a predictor of renal prognosis in immunoglobulin A nephropathy. Annals of Translational Medicine. 8(6). 381–381. 5 indexed citations
19.
Chang, Dan, Yichun Cheng, Ran Luo, et al.. (2020). The prognostic value of platelet-to-lymphocyte ratio on the long-term renal survival in patients with IgA nephropathy. International Urology and Nephrology. 53(3). 523–530. 11 indexed citations
20.
Wang, Lijun, et al.. (2015). MRI features of breast lymphoma: preliminary experience in seven cases. Diagnostic and Interventional Radiology. 21(6). 441–447. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026